Report

Semperit confirmed at BUY, TP EUR 42 - There is more cash to be pocketed beyond the peak year

We found Semperits Q2 results accommodative for our BUY rating and raise the target price to EUR 42 from EUR 40.
The demand recovery in the industrial divisions is ongoing with order books indicated significantly higher.
As regards Sempermed, the quarterly profit climax was arguably achieved in Q2. But this does not mean the story is over. We think that the market is overly cautious about Sempermeds profit generation in the expected deflationary environment and under-appreciates the FCF potential.
The group is very explicit that the expansion of its industrial business is paramount in the capital allocation. Given that the dividend payout is conditional to the financial power needed in M&A, we assert a blurred visibility
Underlying
Semperit Holding AG

Semperit is a holding company, engaged in developing, producing and selling specialized rubber and plastic products for the medical and industrial sectors. Co. has 20 production facilities in 12 countries. In addition, Co. operates a distribution network with branches in Asia, Europe and North and South America. Co.'s products are sold to providers in the medical and industrial sectors, who are supplied with specialised rubber and plastic products. Co.'s main product categories include examination and surgical gloves, hydraulic and industrial hoses, conveyor belts, escalator handrails, construction profiles, cable car rings, ski foils and products for railway superstructures.

Provider
Raiffeisen Bank International AG - Institutional Equity
Raiffeisen Bank International AG - Institutional Equity

The Institutional Equity Research team of Raiffeisen Bank International AG covers 85 stocks from Austria, Central & Eastern Europe with sell-side research and thus levers our local broker status with excellent company relationships. For corporates in Austria, CEE and Western Europe, we offer co-sponsored research, which includes research coverage and marketing activities to investors. Additionally, through our Spotlight Research product we also shed light on leading European small and micro-caps, seeking greater visibility with investors.

The Institutional Equity Research team consists of roughly 15 analysts, both in Vienna and the CEE countries. Our analysts provide long-standing sector expertise in tandem with profound local market know how and a sectoral approach across the entire region.

Other Reports on these Companies
Other Reports from Raiffeisen Bank International AG - Institutional Equity

ResearchPool Subscriptions

Get the most out of your insights

Get in touch